McNeil recalls some Motrin products from retailers

News
Article

FDA announced in late December that McNeil Consumer Healthcare Division of McNeil is voluntarily recalling certain lots of Motrin IB 24-count coated caplets, Motrin IB 24-count coated tablets, and Motrin IB 24+6-count coated caplets from retailers.

FDA announced in late December that McNeil Consumer Healthcare Division of McNeil is voluntarily recalling certain lots of Motrin IB 24-count coated caplets, Motrin IB 24-count coated tablets, and Motrin IB 24+6-count coated caplets from retailers.

The company is recalling the products (about 12 million bottles) because testing of product samples showed that some caplets may not dissolve as quickly as intended when nearing their expiration date.

This is not a consumer-level recall, which means that consumers do not need to dispose of or return the product. There is no safety concern if consumers continue taking the product in accordance with its label; however, it is possible there may be a delay in experiencing relief. This action is not being undertaken on the basis of adverse events.

For a complete list of recalled Motrin products, visit the company’s website.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.